RU-58841 without finassteride? Treatment 6/23/2025
RU58841 is used without finasteride by some due to side effects, with mixed results. Users report combining RU58841 with minoxidil and adjusting finasteride doses to manage hair loss.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 5 months Finasteride + RU58841 + Minoxidil – Progress check
The user shared progress pictures after using Finasteride, RU58841, and Minoxidil for 5 months, reporting no side effects and planning to switch to Dutasteride and oral Minoxidil. They noted that Finasteride and RU58841 helped regrow natural hair, while the transplanted hair remained unchanged.
community Transitioning from fin to RU58841 + Oral Minoxidil - how long until I lose all my fin gains?
The user transitioned from finasteride to RU58841 and oral minoxidil to maintain hair gains while avoiding systemic DHT suppression. They have not experienced increased shedding or side effects since stopping finasteride and hope RU58841 will preserve their hair.
community Finasteride and Topical Minoxidil to Dutasteride and Oral Minoxidil. Is RU58841 still helping?
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, questioning the effectiveness and safety of continuing RU58841. They experienced hair loss improvement initially but are now considering stopping RU58841 due to cost and safety concerns.
community Which 2026 hair‑loss treatments have the strongest evidence so far? (minoxidil/finasteride vs. clascoterone, PP405, Re:You’s NV‑623/624, AMP‑303, RU58841)
Minoxidil and finasteride are the only FDA-approved treatments for androgenetic alopecia, while newer treatments like clascoterone, PP405, NV-623/624, AMP-303, and RU58841 are still experimental with varying levels of evidence. Clascoterone shows the most promise due to strong human data, while AMP-303 has notable early human trial results; RU58841 lacks human data and remains experimental.
community Hair loss still progressing despite finasteride, dutasteride, oral minoxidil, and trying RU58841. What next?
Despite using finasteride, dutasteride, oral minoxidil, and RU58841, hair loss continues to progress. Options considered include increasing dutasteride or minoxidil doses, adding topical treatments, and exploring other potential causes of hair loss.
community 25M, Aggressive Diffuse NW5 – 5 Months Minoxidil + 3 Months Oral Finasteride + RU58841 | Progress or Not?
A 25-year-old with aggressive diffuse NW5 hair loss is using Minoxidil, oral Finasteride, RU58841, Ketoconazole, and dermastamping, experiencing slow progress and mental health struggles. Despite some visible regrowth, the user feels discouraged due to ongoing hair loss and is seeking reassurance and advice.
Related Research
6 / 6 results
research CLINICAL UPDATES IN HAIR
This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.
research Investigational medications in the treatment of alopecia
This review discusses investigational treatments for androgenetic and chemotherapy-induced alopecia and reports no new clinical results, highlighting the need for further research.
research Minoxidil: effectiveness and prospects for use in the treatment of androgenetic alopecia
Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.
research Системная терапия больных андрогенетической алопецией
Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.
research Андрогенетическая алопеция: патогенетические механизмы и подходы к лечению
This article reviews the pathophysiology and limited effectiveness of current treatments for androgenic alopecia, including finasteride, minoxidil, botulinum toxin A, and platelet-rich plasma, and highlights the need for new therapeutic approaches; it reports no new clinical findings.
research Тіе Modern treatment of androgenetic alopecia
This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.